50:53

Podcast # 12 Conversation with Bill Wilson, MD on GLP-1 agonist like Ozempic, Tirzepatide, Wegovy...

11:24

BioAnalysis: Mastering Sample Preparation. Techniques to Elevate Your Bioanalytical Assays #lcms

01:28

Emery Team Celebration: Working Hard Every Day and Bringing Their Best Halloween Style! 😂😂

59:12

Professor Kelly E. Dunn: Fighting Fentanyl with Naloxone: A lifeline Amid the Epidemic

14:00

Developed an LC-MS/MS method to quantify small molecules in surrogate matrix, validated by ICH M10

01:58

Empowering Youth: Boys & Girls Club of Alameda Visits Emery Pharma for Science and Sustainability

09:48

LC-MS/MS Method for Quantitation of Each Monoclonal Antibody in a 6-Component Antibody Cocktail

01:03:45

Genetic Toxicology & Carcinogenicity: Insights on Drug Safety, Mutation Risks, and Cancer Risk

43:17

CAR-T Revolution – Advancing Lymphoma Treatment with Precision & Innovation

01:14:46

"Fructose: The Hidden Fat Factory - Uncovering the Link to Obesity and Fatty Liver" #ObesityCrisis

36:20

Professor Robert Lustig: Can you exercise your way out of a bad diet? #diet #obesity #shorts#lustig

58:45

Hypothesizing on how Nitrosamine Drug Substance Related Impurities (NDSRI's) are being formed?

46:54

IP Considerations Relating To Antibody Drug Conjugates (ADC) #patent #antibody #drugdevelopment #

01:02:58

Unmasking the Sugar Crisis: Dr. Lustig on Obesity, Vitamin D, & Gut Health #SugarCrisis #GutHealth

21:38

Breast Cancer Screening: Enhancing diagnosis with FDA-cleared ATUSA(R) an AI-driven 3D ultrasound.

01:48

Enhancing health with comprehensive pharmaceutical R&D & analytical services. Visit emerypharma.com.

44:13

Analytical Biochemistry Strategy for Gene Therapy Drug Development by Dr. Nesredin Mussa

36:41

Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.

06:56

Antibody Drug Conjugate (ADC) and DAR determination by Dr. Prajita Pandey

05:15

Ligand Binding Assay by Brianna White, MS.c.

01:06:11

Everything You Knew About Obesity is Wrong!

13:05

Podcast: 9 Gas Chromatography Uncovered: Theory Meets Application #analysisservices #gcms #chemistry

08:59

Podcast 8:Advancing Cancer Precision:ADC Breakthroughs & DAR Characterization Insights @Emery Pharma

11:29

Podcast 7: Assuring Excellence! Inside the Role of QA Director in Contract Research Organization

10:08

Podcast 6: Unveiling Glycan Mysteries: LC-MS Insights into Biologics' PTM Impact & Analysis"

04:23

A four minute Overview of Emery Pharma's Analytical and Bioanalytical Chemistry Capabilities

33:57

Click Here for full video: Robert Lustig, WARNING-Ultra Processed Foods Fueling Neurological problem

52:17

Prof. Leslie Benet - UCSF: The explanation for WHY when bioavailability calculation exceed unity?

46:47

Click Here for Richard Johnson, MD : Role of Sugar in Obesity, Diabetes, and Alzheimer

13:59

Unveiling Sugar's Role in Obesity, Diabetes, Alzheimer's

22:23

Click here for full video: Dr. Bill Wilson what is CARB syndrome?

43:15

Dr. Mark Szabo: NMR Spectroscopy. Challenges in Structure Determination, Thermodynamics, & Kinetics

19:28

Watch the full video: Bill Wilson, MD CARB Syndrome due to heavy consumption of processed food

01:18:11

Click here for the full video: Robert Lustig, MD - Food, Metabolism, and Psychiatric Disease

01:01

Robert Lustig, MD: Challenging conventional wisdom. Obesity is not a driver of NAFLD #shorts #nafld

25:55

Bioanalytical method validation vs. analytical method validation by Dr. Ryan Cheu, director of chem.

35:37

Robert Lustig on Fatty Liver, Sugar, Metabolic Syndrome, Ozempic

51:02

Navigating Early Clinical Drug Development Challenges by Dr. Sara Glickstein of Genentech

01:27:47

Prof Roy Gerona UCSF monitoring for New Psychoactive Substances (NPS)

48:00

Biological Carbon Capture (Day or Night) by Professor Shota Atsumi of UC Davis Dept. of Chemistry

01:22:35

Non-Alcoholic Fatty Liver Disease and its Link to Chronic Illnesses, Unraveling the Hidden Epidemic.

28:26

Professor Lustig’s Hateful - Grateful 8, follow up Q & A (with slightly improved audio)

22:01

Bioanalytical Method Validation of a Small Molecule in a Surrogate Matrix by LC-MS/MS

28:26

Robert Lustig, MD "Hateful-Grateful 8" a conversation with Ron Najafi, CEO - Emery Pharma

39:09

Hydroxy Radical Protein Footprinting (HRPF) and its relevance in Drug Development

10:17

Botanical Drug Development Overview

01:14:48

Oncology Drug Modalities: A New Era in Oncology Drug Development

04:23

Emery Pharma Discuss the Basic Principles of Liquid Chromatography Mass Spectroscopy (LC-MS)

59:53

Psychedelics and Related Plasticity - Promoting Neurotherapeutics

53:11

Universal Immunity: Why people don’t generate broad spectrum responses to mutating viruses

04:59

Step-by-Step Glycan Analysis of a Biologic Therapeutic

06:42

Step-by-Step Intact Mass & Subunit Analyses of a Therapeutic Antibody by Hi Res Orbitrap Mass Spec

46:00

Elucidating and Translating The Role of Glycans in Health and Diseases

59:33

The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig

00:36

cGMP NMR Capabilities General Overview

03:03

cGMP NMR Capabilities

04:34

Step-by-step LC-MS Peptide Mapping

19:40

Medicinal Synthetic Chemistry at Emery Pharma

06:10

European Food Safety Authority's (EFSA) Guidance on Antimicrobial Susceptibility Testing

08:52

Poloxamer detection used in applications of gene therapy/delivery